The strong 2026 IPO rebound, already exceeding prior years in both volume and proceeds, anchors trader sentiment for activity before 2027. Through mid-2026, U.S. listings raised over $250 billion across dozens of deals, led by SpaceX’s record $75 billion offering, with broad participation from AI infrastructure, biotech, and consumer sectors amid supportive equity valuations and earnings momentum. Recent September 2026 filings and pricings, including Oura’s planned Nasdaq debut targeting over $16 billion, alongside confidential submissions from Anthropic and others, point to continued deal flow through year-end. Key variables include equity market stability, interest rate paths, and timing decisions by high-profile names weighing 2026 versus 2027 windows due to valuation and reporting considerations.